LIVE

Serial Number

79404339

Owner

REGENERA ACTIVA WORLDWIDE S.L.

Attorney

Ben Natter

Filing Date

Jun 13, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ESTRIAEPHIL AUTOLOGOUS EXOFILL Trademark

Serial Number: 79404339 • Registration: 7971474

ESTRIAEPHIL AUTOLOGOUS EXOFILL is a trademark filed by REGENERA ACTIVA WORLDWIDE S.L. on June 13, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

REGENERA ACTIVA WORLDWIDE S.L. (2 trademarks)

Calle Sant Ferran, Num. 10 P.BJ

Entity Type: 16

REMEDI S.à. r.l. (3 trademarks)

89 B, Rue Pafebruch

Entity Type: 99

Legal Representation

Attorney of Record

Ben Natter

6,523 trademarks filed View all →

Correspondence Address

Ben Natter Haug Partners LLP

745 Fifth Avenue

New York, NY 10151

United States

Trademark Details

Filing Date

June 13, 2024

Registration Date

October 7, 2025

Published for Opposition

August 19, 2025

Goods & Services

Medical apparatus and instruments, namely, mechanical disruptors that disaggregates tissue for regenerative purposes; medical devices for tissue-regeneration

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 30, 2026 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Apr 12, 2026 FICS

FINAL DISPOSITION PROCESSED

Apr 12, 2026 FIMP

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Feb 26, 2026 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 11, 2026 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Feb 11, 2026 OPNR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 7, 2026 FICR

NEW REPRESENTATIVE AT IB RECEIVED

Dec 25, 2025 NREP

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 7, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Oct 7, 2025 R.PR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 3, 2025 NRCC

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 19, 2025 NPUB

PUBLISHED FOR OPPOSITION

Aug 19, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 13, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 11, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 9, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 9, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 9, 2025 TROA

CHANGE OF OWNER RECEIVED FROM IB

Mar 13, 2025 CHLD

REFUSAL PROCESSED BY IB

Feb 9, 2025 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 18, 2025 RFCS

REFUSAL PROCESSED BY MPU

Jan 18, 2025 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 22, 2024 RFCR

NON-FINAL ACTION WRITTEN

Dec 21, 2024 CNRT

ASSIGNED TO EXAMINER

Dec 18, 2024 DOCK

APPLICATION FILING RECEIPT MAILED

Oct 7, 2024 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 7, 2024 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Sep 19, 2024 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Sep 12, 2024 REPR

Related Trademarks

More from this Owner

MYTOCEL MSK

R REMEDI

More in Same Class

NEUROBUDS

R REMEDI